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ABSTRACT
Cardiac abnormalities affecting heart rate and rhythm are commonly
observed in both healthy and acutely unwell people. Although many
of these are benign, they can sometimes indicate a serious health
risk. ECG monitors are typically used to detect these events in elec-
trical heart activity, however they are impractical for continuous
long-term use. In contrast, current-generation wearables with optical
photoplethysmography (PPG) have gained popularity with their low-
cost, lack of wires and tiny size. Many cardiac abnormalities such
as ectopic beats and AF can manifest as both obvious and subtle
anomalies in a PPG waveform as they disrupt blood flow. We pro-
pose an automatic method for recognising these anomalies in PPG
signal alone, without the need for ECG. We train an LSTM deep
neural network on 400,000 clean PPG samples to learn typical PPG
morphology and rhythm, and flag PPG signal diverging from this
as cardiac abnormalities. We compare the cardiac abnormalities our
approach recognises with the ectopic beats recorded by a bedside
ECG monitor for 29 patients over 47.6 hours of gold standard ob-
servations. Our proposed cardiac abnormality recognition approach
recognises 60%+ of ECG-detected PVCs in PPG signal, with a false
positive rate of 23% – demonstrating the compelling power and
value of this novel approach. Finally we examine how cardiac abnor-
malities manifest in PPG signal for in- and out-of-hospital patient
populations using a wearable device during standard care.
1 INTRODUCTION
Many cardiac abnormalities affecting heart rate and rhythm are ob-
served in both healthy and acutely unwell populations. These often
present through arrhythmias, where the heart beat is either persis-
tently or occasionally irregular, too fast or too slow. While there are
many different types of arrhythmias, among the most common are
tachycardia (i.e., >120 beats/min), bradycardia (i.e., <45beats/min),
atrial fibrillation (AF) and flutter (i.e., disordered and fluctuating
heart beats) and ectopic beats such as premature ventricular and
atrial contractions (i.e., PVCs/PACs).
Many arrhythmias are asymptomatic or benign, and can occur
in otherwise healthy individuals seemingly randomly. However, at
increasing frequency for patients in high risk groups, they may be
a precursor to, or part of an acute condition. AF has been shown
to predispose a patient to stroke or heart failure. PVCs have been
shown to manifest with cardiomyopathy and myocardial infarction.
An electrocardiogram (i.e., ECG, or EKG) measuring electrical
activity in the heart over time is the main diagnostic approach for
investigating cardiac abnormalities. An ECG examination requires
a patient to have 2, 6 or 12 leads connected to electrodes correctly
attached to skin across their chest and limbs. Bedside and portable
telemetry Holter ECG monitors are the clinical gold standard for
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Figure 1: 6-second PPG signal samples. (a) is a regular rhyth-
mic PPG signal, while (b), (c) and (d) contain cardiac anomalies.
accurate cardiac diagnosis. However, they are impractical or uncom-
fortable for long-term continuous use in ambulatory patients, so
ECG investigations typically only take place over relatively short pe-
riods of time for patients who have presented other symptoms which
warrant the investigation. As a result, many rarer, asymptomatic or
early-onset cardiac conditions can be missed.
In contrast, conveniently small, unobtrusive and inexpensive wear-
able devices such as smart watches and fitness trackers which include
a photoplethysmography (PPG) sensor to monitor the user’s pulse
have become extremely popular. PPG is an optical sensing technique
which transmits specific light wavelengths into well-perfused skin
tissue, and measures the amount of light reflected back - thereby
measuring the changing volume of blood in the tissue over time
following each pulse wave ejected from the heart. A typical real
wearable device pulsatile PPG waveform is shown in Figure 1(a).
Under normal conditions, the heart atria and ventricles contract
sequentially to pump blood into the arterial system. Under abnormal
conditions there can be a mistiming of contractions (e.g., a PVC),
which can cause faster rhythm and reduced cardiac output. Similarly,
reduced or no atrial contraction with erratic ventricular contraction
(e.g., AF) can lead to random heart rate and cardiac output.
As PPG only measures the output of the heart into the circula-
tory system, it cannot fully characterise the underlying heart activity
which preceded it as with the fidelity of an ECG. However, since
many cardiac abnormalities affect the heart’s pulse wave output, they
can disrupt in various ways – albeit sometimes subtly – blood flow
and thus ‘glitch’ subsequent PPG waveform rhythm and morphol-
ogy. Real examples of brief cardiac anomalies disrupting the PPG
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waveform morphology are shown in Figures 1(b), (c) and (d). Ac-
cordingly, we posit that deeper analysis of PPG waveforms beyond
just pulse rate can provide clues of cardiac function from a wearable
device PPG sensor worn comfortably all the time. This has the po-
tential to dramatically increase the clinical value of data from the
current generation of PPG-based wearable devices. Firstly, cardiac
abnormality clues identified in wearable PPG can be used to flag
the patient for a thorough ECG investigation. Secondly, monitoring
these types of events in broader populations may lead to new in-
sights around their long-term and large-scale occurrence and impact
in general populations. Finally, these clues may provide a salient
signal of cardiac function which can augment health deterioration
early warning algorithms – allowing them to make earlier and more
accurate predictions for many serious health conditions.
2 RELATEDWORK
Finding "surprising/interesting/unexpected/novel" sub-sequences in
time series is generally referred to as anomaly detection [6]. A
wide body of literature originating in machine learning and statistics
has developed generalisable and domain-specific anomaly detection
and classification techniques, typically based on learning common
patterns and expected statistical distributions [2].
Anomaly detection and classification approaches have long been
applied to ECG and electroencephalography (EEG) signals. For ex-
ample, [8] used deep learning to identify cardiac events in ECG.
ECG data has very distinctive morphology (i.e., PQRST waveform
complex), and many algorithms have been built into ECG monitors
to automatically classify certain cardiac conditions such as ST ele-
vation with high precision. In contrast, PPG contains less time and
frequency domain information, and is more susceptible to calibration
and motion artefact noise, so requires a different approach. Specifi-
cally for recognising PPG waveforms impacted by artefacts, Signal
Quality Indices (SQI) identify good and bad PPG signals [3, 7]. SQI
are heuristic-based models, based on the timing of pulse waves and
known physiological distributions. They classify larger fragments
of signal as a binary good or bad, and are not designed to highlight
specific anomalous regions of PPG signal.
3 PPG ANOMALY DETECTION
Artefacts in PPG can originate from many sources, including (i)
physiological abnormalities (e.g., cardiovascular issues), (ii) motion
corruption, and (iii) poor PPG calibration (i.e., how much light to
transmit into the skin - which is affected by skin colour, circulation,
adipose tissue and sensor contact pressure). As we are interested in
recognising physiological artefacts - our approach must first rule
out that the source of any anomaly recognised is not from motion
or calibration issues. Consequently, the snap40 upper-arm wearable
device employs various continuous proprietary calibration routines
which quickly recalibrate the PPG signal if it is compromised, e.g.,
the patient moves the device for comfort to a location on their arm
with different tissue properties. Moreover, the snap40 device discards
PPG signal data when wearer motion will irretrievably corrupt the
PPG signal. Since cardiac abnormality analysis is very sensitive to
small perturbations in the waveform caused by motion, we set the
motion filtering level to ’very still’, in laying or sitting postures.
Input PPG signal Auto-encoded PPG signal
Figure 2: Input PPG and autoencoded counterpart examples.
Note the autoencoder failing to reproduce anomalous regions.
Our proposed cardiac abnormality detection approach comprises
two stages. Firstly, we train an autoencoder to learn what typical
normal PPG morphology and rhythm looks like. To this end, we
employ a deep recurrent neural network LSTM autoencoder which
is capable of learning the time- and freqency-domain patterns found
in clean PPG signal. Secondly, we use this autoencoder to encode
and then reconstruct the input PPG signal based on its reduced di-
mensionality representation. By measuring the differences between
autoencoded and original PPG signals, we identify regions of the
PPG signal that the constrained autoencoder representation fails to
sufficiently reproduce – i.e., the specific anomalies. This unsuper-
vised approach allows us to recognise anomalies without needing to
explicitly label an anomaly training set at scale.
3.1 Deep-learnt Autoencoder Implementation
Abstractly, an autoencoder learns, without supervision, an optimal
reduced dimensionality representation of its training examples given
permitted representational complexity (i.e., the number of neurons
and hidden layers). In this application, an autoencoder provides an
unsupervised method of learning the common and defining morpho-
logical and rhythm patterns of PPG signals. Accordingly, anything
that is atypical in the input PPG signal is not encoded/decoded in
the subsequent autoencoder output.
Two examples of PPG signal including cardiac abnormalities,
and their autoencoded counterparts, are presented in Figure 2. Note
how the autoencoder adequately reproduces components which have
time and frequency typically seen in regular PPG signal, however
falters around unusual patterns – it is this faltering that allows to us
to automatically recognise and flag specific abnormal PPG regions.
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Figure 3: (a) and (b) show windowed Pearson’s r autoencoder
reconstruction error from the PPG examples presented in Fig-
ure 2. Flagged PPG anomalies are shown in (c) and (d).
So the autoencoder does not learn to represent and reproduce
the anomaly patterns we wish to expose, it is essential it is trained
using only clean PPG signal samples without abnormalities. Accord-
ingly, we constructed a dataset of approximately 400,000 8-second
clean and regular PPG signal samples from 300+ real patients, boot-
strapped by semi-supervised FFT-based frequency analysis on a
random sample of around 2,000 PPG fragments. We do not explic-
itly label any specific anomalies. As human physiology often follows
many heavy-tailed distributions, and a deep-learnt model requires a
lot of training examples to be effective, a training set of this scale
is necessary to reliably include clinically expected pulse rates of
35-180 beats/min, and various common physiologies such as high
and low, but not abnormal, heart rate variabilities.
Digital signal processing (DSP) filtering was used to clean, down-
sample and normalise PPG signal for the autoencoder. Since PPG
is a time series, the autoencoder is a sequence-to-sequence model,
implemented as a long-short term memory (LSTM) recurrent neural
network in Tensorflow [1]. Preliminarily, we used a 2-layer (with
80/40 neurons) LSTM. However, optimal neural network architec-
ture and training is entirely dependent on the device sensor character-
istics, DSP pipeline used, run-time constraints, training computation
availability, training data scale and desired sensitivity goals.
3.2 Flagging Anomalous PPG Regions
Anomalous PPG signal regions are identified when the original PPG
signal and its autoencoded counterpart diverge, as measured by a
difference metric. Importantly for healthcare, this approach supports
explainability as it explicitly flags specific irregular PPG signal
regions for further automated analysis or manual human review.
We found absolute error as a difference metric is overly sensitive
to occasional autoencoder underfitting for low frequency modulation
in the PPG signal due to respiratory and parasympathetic induced
variation [4]. Future work to increase training data, using longer
PPG length and neural network tuning will likely alleviate this.
Instead, computing Pearson’s r correlation co-efficient over sliding
windows of the input PPG signal and its autoencoded counterpart
was sufficient to reliably recognise anomalous regions. Sensitivity of
the anomaly detection is governed by both the size of these windows
and the r selected as an anomaly threshold. We selected half-second
windows, with anomaly level r < 0.6 for experiments in Section 4.
In Figures 3(a) and (b), we present the aligned autoencoder error,
as measured by Pearson’s r. The respective Figures 3(c) and (d),
show the identified anomalies, defined as periods where r falls be-
low 0.6. Figure 3(c) shows multiple similar anomalies manifesting
rapidly, with two dominant faster/slower frequencies manifesting
in the PPG signal. Meanwhile, Figure 3(d) shows a single anomaly
which is prominent compared to its surrounding PPG context.
4 EXPERIMENT, RESULTS & DISCUSSION
To preliminarily evaluate and analyse the potential of our proposed
approach, we investigate clinical and wearable sensor data from
hundreds of clinical study patients with a range of pathologies and
acuities being cared for in different settings in the UK and USA (e.g.,
in hospital wards, during surgery and at home).
Following recruitment, patients wore the snap40 device on the
upper-arm for one hour to ten days while undergoing standard care.
The snap40 device passively captured low-motion green PPG sensor
data, and wirelessly transmitted high fidelity waveforms for post-hoc
analysis. The clinical studies and their respective patient populations
were as follows: HDU: (medical/surgical high-dependency unit),
comprises 120 patients who are high acuity and continuously mon-
itored, wearing the device during the day. AMU: (acute medical
unit) consists 250 patients higher acuity patients who have been
recently admitted to hospital, wearing the device for up to 10 days,
24 hours a day. SURGERY: consists 30 peri- and post-operative
general surgery patients, wearing the device for up to 2 days, 24
hours a day. ED: consists of 250 emergency department patients of
varying acuity, wearing the device between 30-240 minutes, dur-
ing the day. HOME: consists of 8 heart bypass patients for 2 days
post-discharge to home care, wearing the device 24 hours a day.
In Section 4.1, we first examine the accuracy and sensitivity of
the proposed approach for recognising known cardiac abnormalities
in PPG signal, compared to abnormalities (i.e., PVCs) recognised
by a conventional bedside ECG monitor. Of course PVCs are only
one type of cardiac abnormality, so this initial methodology provides
an initial insight into performance using ECG-based gold standard
(GS) PVC detection as a first proxy for real abnormal cardiac events.
Since few patients receive continuous ECG monitoring, even in the
hospital, this evaluation is based on the subset of HDU patients who
had leads correctly attached for continuous ECG monitoring for
whom we have data available. For these patients, we have a once-a-
minute count of the zero or more PVCs detected in their ECG over
that minute. We align available wearable PPG sensor data over each
of those minutes, and compute set-based comparative evaluation
measures (i.e., classification accuracy) based on the presence or
absence of anomalies detected in the aligned PPG, and respective
GS PVCs. We filter GS PVCs to those where there is at least 30-
seconds of high quality aligned wearable PPG signal available.
Following this, in Section 4.2 to understand how cardiac ab-
normalities manifest at large in PPG signal collected from diverse
patient populations, we analyse the overall and per-patient frequency
of the cardiac abnormalities detected with our proposed approach.
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4.1 Comparative ECG Gold Standard Evaluation
Our test dataset contains 29 patients with a total of 2,852 zero or
more PVCs/min GS observations (i.e., 47.6 hours ECG monitoring,
averaging 98 minutes of observations per patient), where each GS
observation has ≥ 30 seconds of aligned good quality PPG signal.
2,465 (86.4%) of the GS PVCs/min are 0 PVCs/min observations,
387 (13.6%) are >= 1 PVCs/min observations while 195 (6.8%) are
>= 2 PVCs/min observations. At the extreme, one patient has a GS
observation with 7 PVCs/min; showing PVCs are heavily skewed.
In Table 1, we present the set-based detection accuracy confusion
matrix for recognising GS PVCs (when there is >= 1 PVC/min) in
PPG signal using our proposed approach. Our proposed approach
successfully recognises around 60% of PVCs in the PPG signal alone,
and incorrectly recognises 23% of PPG signals without a PVC as
having a cardiac abnormality. This may be a genuine approach error,
or it could be another type of cardiac abnormality. Additionally,
because of our high-motion PPG filtering, we do not have complete
PPG signal coverage over the gold standard periods, so may miss
some PVCs with this methodology limitation. Furthermore, the gold
standard itself will also have PVC classification error. [5] found
of 22,509 arrhythmia alarms analysed, 27.4% where false alarms
which grew to 91.4% for acute life-threatening alarms, with no
events missed – indicating a preference for false positives rather than
false negatives, thus affecting our evaluation metrics.
Allowing 1 or more PVCs/min in the GS means cardiac abnormal-
ities are rare for the majority of GS observations. Accordingly, we
compute the confusion matrix when there are 2 or more PVCs/min
present in the GS. This increases true positives to 132 (68%) - show-
ing that when cardiac abnormalities are more prevalent, our PPG-
based approach is increasingly more effective in recognising them.
Overall these initial results are very encouraging as they demon-
strate that even with a limited evaluation methodology, a basic model
can achieve reasonable sensitivity while maintaining specificity. Fu-
ture work will investigate more robust methods to identify anomalies
in autoencoder output, and if possible, classify the specific cardiac
events which caused them.
4.2 Patient Population Analysis
We use our proposed approach to identify cardiac abnormalities
in over ten thousand hours of PPG data randomly sampled from
several large-scale clinical studies using the snap40 wearable device.
Analysis results are presented in Table 2.
Patient demographics and biases can explain many of the cardiac
abnormality differences between populations. Expectedly, the often
older and higher acuity patients in HDU and AMU had the most PPG
samples with cardiac anomalies (i.e., 5.1% and 5.8%, respectively).
In contrast, recently discharged patients at HOME had fewer PPG
samples with cardiac abnormalities overall (i.e., 3.52%) - and with
lesser variability indicating more stable cardiac health compared to
in-patients. Likewise, ED has a wide range of patient acuities (indeed
many will go to AMU), so while it has on average a lower PPG-based
cardiac abnormality occurrence (i.e., 3.1%), some patients have far
more as shown by the large variability (i.e., ±7.9%). Interestingly,
SURGERY patients had the fewest PPG samples with cardiac ab-
normalities, perhaps due to selection of fitter patients eligible for
surgery, close monitoring or perhaps therapeutic effects.
Anomaly in PPG ✓ Anomaly in PPG ✗
PVC in ECG ✓
231
(59.7% true positive)
156
(40.0% false negative)
PVC in ECG ✗
574
(23.2% false positive)
1,891
(76.7% true negative)
Table 1: Set-based detection accuracy confusion matrix for
recognising ECG-based GS PVCs (when there is >= 1 PVC/min)
in aligned PPG signal using our proposed approach.
% of PPG samples with anomalies,
per patient
Population: Avg (Stdev) Max
HDU 5.10% (±5.0%) 17.4%
SURGERY 1.54% (±2.2%) 6.9%
ED 3.17% (±7.9%) 59.1%
AMU 5.75% (±11.9%) 61.5%
HOME 3.52 (±1.9%) % 5.8%
Table 2: Frequency of cardiac abnormalities recognised in PPG
samples, aggregated per patient, in each patient population.
5 CONCLUSION
Cardiac abnormalities such as ectopic beats and AF manifest in a
wearable device PPG waveform as they disrupt blood flow. Some
of these abnormalities are benign, while others can be a serious
health risk factor. Accordingly, identifying cardiac abnormalities in
PPG signals provided by a conveniently practical wearable device,
as opposed to conventional inconvenient ECG monitors requiring
multiple electrodes and leads can be valuable.
We demonstrated that cardiac abnormalities, where PPG signal
deviates from typical morphology and rhythm, can be recognised in
wearable PPG signal with an unsupervised deep-learnt autoencoder
anomaly detection approach. Preliminary evaluation on a large ECG-
based gold standard dataset showed our approach recognises 60%+
of ECG-detected PVCs in PPG signal, with a false positive rate of
23%. Expectedly, analysis of several large clinical study datasets
showed cardiac abnormalities detected are more frequent in higher
acuity patients. Future work will enhance accuracy and sensitivity,
and explore specific cardiac event classification.
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